Author:
Bashir Hassaan H.,Jankovic Joseph
Funder
Allergan
CHDI Foundation
Dystonia Coalition
F. Hoffmann-La Roche Ltd
Huntington Study Group
Medtronic Neuromodulation
Merz Pharmaceuticals
Michael J Fox Foundation for Parkinson Research
National Institutes of Health
Neurocrine Biosciences
Parkinson's Foundation
Parkinson Study Group
Revance Therapeutics, Inc
Teva Pharmaceutical Industries
Reference119 articles.
1. Neurological symptoms in pharmacotherapy of psychoses;Faurbye;Acta Psychiatr Scand,1964
2. Reversible and irreversible dyskinesia after treatment with perphenazine, chlorpromazine, reserpine and electroconvulsive therapy;Uhrbrand;Psychopharmacologia,1960
3. An update on tardive dyskinesia: from phenomenology to treatment;Waln;Tremor Other Hyperkinet Mov (N Y),2013
4. Tardive dyskinesia: a historical perspective;Macaluso;J Psychiatr Pract,2017
5. Tardive syndromes;Savitt;J Neurol Sci,2018
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献